Compare

Givaudan SA/€GIVN

1D1W1MYTD1Y5YMAX

About Givaudan SA

Givaudan SA operates in the flavor and fragrance industry, providing innovative products and solutions to food, beverage, consumer goods, and fragrance companies. Headquartered in Vernier, Switzerland, the company develops flavors for the food and beverage industry and fragrance solutions for personal care, home care, and fine fragrance products. Givaudan's offerings are segmented into Taste & Wellbeing and Fragrance & Beauty, with a focus on innovation and sustainability. With a presence in over 180 locations globally, Givaudan leverages its extensive R&D capabilities and industry expertise to maintain a competitive edge in creating tailored, high-quality solutions for its clients.
Ticker
€GIVN
Sector
Materials
Primary listing
XGAT
Employees
17,508
Headquarters
Vernier, Switzerland
Website
www.givaudan.com

Givaudan SA Metrics

BasicAdvanced
€33B
32.80
€110.13
0.66
€78.64
2.18%

What the Analysts think about Givaudan SA

Analyst ratings (Buy, Hold, Sell) for Givaudan SA stock.
Analyst projections of the future price of Givaudan SA stock.

Bulls say / Bears say

Organic growth is gaining momentum. Second-quarter like-for-like sales rose 4.3%, ahead of consensus, while Fragrance & Beauty grew 6.5% in the first half and Taste & Wellbeing showed a sequential improvement. (Reuters, Givaudan)
Management has reaffirmed a 2030 target of 4–6% average like-for-like sales growth and more than 12% average adjusted free cash flow. The plan also targets higher-value adjacencies in beauty, wellbeing, nutrition and biotechnology, giving the group a longer-term growth runway. (Givaudan, Givaudan)
Recent investments could strengthen Givaudan’s competitive position in regional fragrances and specialist technology. The Eurofragance majority stake expands local-market reach, while the Microcaps collaboration adds patented microencapsulation capability for longer-lasting and non-alcoholic fragrances. (Givaudan, Givaudan)
First-half profitability weakened materially despite positive organic growth. Net income fell 19.8% to CHF 475 million, adjusted EBITDA margin declined to 24.3% from 25.2%, and CHF 103 million of non-recurring costs included litigation and investigation-related items. (Reuters, Givaudan)
Taste & Wellbeing remains a weak spot. It delivered only 0.5% like-for-like growth in the first half, after a 0.4% decline in the first quarter, with North America and Latin America both declining in the first half. (Givaudan, Givaudan)
The shares still command a premium valuation. Morningstar reports a normalised P/E of 31.33 times and price-to-sales ratio of 4.25 times, versus 21.93 times and 2.40 times respectively for IFF, leaving less room for disappointing growth or margins. (Morningstar)
Data summarised monthly by Lightyear AI. Last updated on 25 Sept 2026.

Givaudan SA Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Givaudan SA Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.